These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32640663)

  • 1. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas.
    Campos MA; Macedo S; Fernandes MS; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32640663
    [No Abstract]   [Full Text] [Related]  

  • 2. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
    Campos MA; Macedo S; Fernandes M; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
    J Am Acad Dermatol; 2019 Mar; 80(3):660-669.e6. PubMed ID: 30165166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor.
    Blokx WA; Ruiter DJ; Verdijk MA; de Wilde PC; Willems RW; de Jong EM; Ligtenberg MJ
    Am J Surg Pathol; 2005 Jan; 29(1):125-30. PubMed ID: 15613867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin.
    Küsters-Vandevelde HV; Van Leeuwen A; Verdijk MA; de Koning MN; Quint WG; Melchers WJ; Ligtenberg MJ; Blokx WA
    Int J Cancer; 2010 May; 126(9):2123-32. PubMed ID: 19739123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors.
    Yilmaz AS; Ozer HG; Gillespie JL; Allain DC; Bernhardt MN; Furlan KC; Castro LT; Peters SB; Nagarajan P; Kang SY; Iwenofu OH; Olencki T; Teknos TN; Toland AE
    Cancer; 2017 Apr; 123(7):1184-1193. PubMed ID: 27906449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
    Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of metastatic cutaneous squamous cell carcinoma.
    Li YY; Hanna GJ; Laga AC; Haddad RI; Lorch JH; Hammerman PS
    Clin Cancer Res; 2015 Mar; 21(6):1447-56. PubMed ID: 25589618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma.
    Omura G; Ando M; Ebihara Y; Saito Y; Kobayashi K; Fukuoka O; Akashi K; Yoshida M; Asakage T; Yamasoba T
    BMC Cancer; 2017 Dec; 17(1):898. PubMed ID: 29282038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin18B predicts favorable prognosis of cutaneous squamous-cell carcinoma.
    Cao C; Zhang C; Sun Y; Mu Z; Shen Q
    Genes Genomics; 2021 Apr; 43(4):371-378. PubMed ID: 33555505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma.
    Zhao G; Bae JY; Zheng Z; Park HS; Chung KY; Roh MR; Jin Z
    Anticancer Res; 2019 Apr; 39(4):1849-1857. PubMed ID: 30952725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF1R signaling induces epithelial-mesenchymal plasticity via ITGAV in cutaneous carcinoma.
    Lopez-Cerda M; Lorenzo-Sanz L; da Silva-Diz V; Llop S; Penin RM; Bermejo JO; de Goeij-de Haas R; Piersma SR; Pham TV; Jimenez CR; Martin-Liberal J; Muñoz P
    J Exp Clin Cancer Res; 2024 Jul; 43(1):211. PubMed ID: 39075581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
    Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
    Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome and cytogenetic profiling analysis of matched in situ/invasive cutaneous squamous cell carcinomas from immunocompetent patients.
    García-Díez I; Hernández-Muñoz I; Hernández-Ruiz E; Nonell L; Puigdecanet E; Bódalo-Torruella M; Andrades E; Pujol RM; Toll A
    Genes Chromosomes Cancer; 2019 Mar; 58(3):164-174. PubMed ID: 30474248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions.
    Marinescu A; Stepan AE; Mărgăritescu C; Marinescu AM; Zăvoi RE; Simionescu CE; Niculescu M
    Rom J Morphol Embryol; 2016; 57(2 Suppl):691-696. PubMed ID: 27833960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma.
    Cañueto J; Cardeñoso E; García JL; Santos-Briz Á; Castellanos-Martín A; Fernández-López E; Blanco Gómez A; Pérez-Losada J; Román-Curto C
    Br J Dermatol; 2017 May; 176(5):1279-1287. PubMed ID: 27510450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoblastoma gene expression in human non-melanoma skin cancer.
    Edwards MJ; Thomas RC; Wong YL
    J Cutan Pathol; 2003 Sep; 30(8):479-85. PubMed ID: 12950498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: a marker of metastatic risk.
    Toll A; Gimeno-Beltrán J; Ferrandiz-Pulido C; Masferrer E; Yébenes M; Jucglà A; Abal L; Martí RM; Sanmartín O; Baró T; Casado B; Gandarillas A; Barranco C; Costa I; Mojal S; García-Patos V; Pujol RM
    J Am Acad Dermatol; 2012 Dec; 67(6):1310-8. PubMed ID: 22521203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients.
    Stark LA; Arends MJ; McLaren KM; Benton EC; Shahidullah H; Hunter JA; Bird CC
    Br J Cancer; 1994 Oct; 70(4):662-7. PubMed ID: 7917913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras and p53 mutations and overexpressions as prognostic factors in female rectal carcinoma.
    Hirvikoski P; Auvinen A; Servomaa K; Kiuru A; Rytömaa T; Makkonen K; Kosma VM
    Anticancer Res; 1999; 19(1B):685-91. PubMed ID: 10216477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.